Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) Announces Late-Breaking Data for HeartLogic Heart Failure Diagnostic

September 19, 2017 9:26 AM
Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles